Friday’s Missed Shots: Retail, Inflation & Banks
Thank God it was Friday, as after the disappointing Retail Sales, weaker-than-expected CPI and bank earnings, most likely needed a drink. (Personal choice on a hot summer night is Tanqueray® Rangpur & tonic with cucumber, lime, and some shaved ginger.) Retail Sales Retail Sales missed for the second month in a row and were down 0.2 percent […]
Mortgage REITs Have Paid Off Well
The market for real estate investment trusts (REITs) has been choppy this year. Let me be more specific: The market for equity REITs has been choppy. Mortgage REITs – at least those inside the portfolios of two exchange-traded funds – have been on a quiet tear. It’s uncertain if that will continue. Equity REITS hold […]
Where’s The Froth?
Today it’s in the Chinese markets. We’ll see if today’s sell-off continues, in light of my comments of June 29th and whether it eventually negatively affects other world markets. Source Source
Yen Will Drag Gold Down
Gold has been bouncing higher for a little more than a week, and my view is that, as it approaches its gap at $117.95, it will reverse lower. Whether it’ll reach the gap or not at all remains to be seen, but I’ve shorted it this morning with a stop at $118. Of aid to this trade would […]
The Number One Rule Of Risk Management: Trade Within Your Means
I am asked quite often how I have managed to stick around as an options trader for as long as I have – more than fifteen years and counting. The long answer is that I’ve studied my successes and failures along the way and learned how I behave under certain conditions and deal with adversity. […]
Morgan Stanley: “Market Is So Distorted” The Fed Is Being Forced Into A “Pain Trade”
Add Morgan Stanley to the list of banks who are lashing out against the Fed’s interminable easy monetary policy (as we pointed out last week, the most notable recent entrant was Bank of America which had a simple message to Yellen: “Take That Punch Bowl Away”). In a note from Morgan Stanley’s Hans Redeker, which […]
Equity ‘Strategists’ Selling Financial Pain To The Gullible
Every cycle, a parade of fresh-faced financial analysts salespeople are commissioned to keep the gullible masses buying ‘investment’ products against all odds. Last week, Kate Moore–who began her sell-side career with Bank of America Merrill Lynch in November 2009, before moving up the ranks at JP Morgan in 2013, and to Chief Equity ‘Strategist’ for BlackRock in 2016–explained […]
BlackRock Can Still Have A Giant Future, Despite Earnings
Unfortunately, BLK did not meet market expectations and underperformed on Q2 EPS and revenue expectations. Estimize predicted the world’s largest asset manager to post EPS of $5.40 and Wall Street predicted $5.37; the actual was $5.24. However, Estimize and The Street were more in line regarding revenue. Both predicted $2.979B and $2.974B respectively and BLK […]
Orion Engineered Carbons – Chart Of The Day
The Chart of the Day is the break-out chart of Orion Engineered Carbons (OEC). I found the carbon black stock by using Barchart to sort today’s All Time High list first by the most frequent number of new highs in the last month, then again by technical buy signals of 80% or more. Since the Trend Spotter signaled a buy on […]
E Immune Pharmaceuticals: Two For The Price Of One
Immune Pharmaceuticals (Nasdaq: IMNP), a biopharmaceutical company undergoing a restructuring to split its wide-ranging, diversified portfolio into two pure play companies, has garnered much media attention in the past few days. Immune, the parent company, and its recent subsidiary, Cytovia, are gearing up for an anticipated full split with new patent filings, strategic deals for […]
